Authors:
CHIZZOLINI C
REZZONICO R
WOLLHEIM FA
DAYER JM
Citation: C. Chizzolini et al., RESISTANCE TO INHIBITION OF TYPE-I COLLAGEN PRODUCTION BY SYSTEMIC-SCLEROSIS FIBROBLASTS UPON CONTACT WITH ACTIVATED TH1 TH0 CELLS/, European cytokine network, 9(3), 1998, pp. 504-504
Citation: Fa. Wollheim, SILICONE BREAST IMPLANTS AND CONNECTIVE-TISSUE DISEASE - DO WE NEED MORE ANECDOTES, Journal of clinical rheumatology, 4(3), 1998, pp. 116-117
Authors:
ZEIDLER HK
KVIEN TK
HANNONEN P
WOLLHEIM FA
FORRE O
GEIDEL H
HAFSTROM I
KALTWASSER JP
LEIRISALOREPO M
MANGER B
LAASONEN L
MARKERT ER
PRESTELE H
KURKI P
Citation: Hk. Zeidler et al., PROGRESSION OF JOINT DAMAGE IN EARTH ACTIVE SEVERE RHEUMATOID-ARTHRITIS DURING 18 MONTHS OF TREATMENT - COMPARISON OF LOW-DOSE CYCLOSPORINEAND PARENTERAL GOLD, British journal of rheumatology (Print), 37(8), 1998, pp. 874-882
Authors:
KVIEN TK
ZEIDLER HK
HAUNONEN P
WOLLHEIM FA
KURKI P
Citation: Tk. Kvien et al., 3-YEAR CHANGES IN RADIOGRAPHIC DAMAGE AND PHYSICAL-DISABILITY IN 278 RHEUMATOID-ARTHRITIS (RA) PATIENTS RANDOMIZED TO GOLD (GST) OR CYCLOSPORINE (CYA), Arthritis and rheumatism, 41(9), 1998, pp. 731-731
Authors:
SCHEIA A
HESSELSTRAND R
WILDT TA
AKESSON A
WOLLHEIM FA
Citation: A. Scheia et al., COLLAGEN-I TELOPEPTIDE IN SYSTEMIC-SCLEROSIS IS INCREASED AND CORRELATES WITH DISEASE SEVERITY, Arthritis and rheumatism, 41(9), 1998, pp. 1750-1750
Authors:
CHIZZOLINI C
REZZONICO R
RIBBENS C
BURGER D
WOLLHEIM FA
DAYER JM
Citation: C. Chizzolini et al., INHIBITION OF TYPE-I COLLAGEN PRODUCTION BY DERMAL FIBROBLASTS UPON CONTACT WITH ACTIVATED T-CELLS - DIFFERENT SENSITIVITY TO INHIBITION BETWEEN SYSTEMIC-SCLEROSIS AND CONTROL FIBROBLASTS, Arthritis and rheumatism, 41(11), 1998, pp. 2039-2047
Citation: Fa. Wollheim, DISEASE-MODIFYING DRUGS IN RHEUMATOID-ARTHRITIS (VOL 314, PG 766, 1997), BMJ. British medical journal, 314(7087), 1997, pp. 1063-1063
Citation: Fa. Wollheim, DISEASE-MODIFYING DRUGS IN RHEUMATOID-ARTHRITIS - ENCOURAGING SIGNS BUT EFFECTS NOT PROVED, BMJ. British medical journal, 314(7083), 1997, pp. 766-767
Authors:
LINDROTH Y
BRATTSTROM M
BELLMAN I
EKESTAF G
STROMBECK B
STENSHED B
WIKSTROM I
NILSSON JA
WOLLHEIM FA
Citation: Y. Lindroth et al., A PROBLEM-BASED EDUCATION-PROGRAM FOR PATIENTS WITH RHEUMATOID-ARTHRITIS - EVALUATION AFTER 3 AND 12 MONTHS, Arthritis care and research, 10(5), 1997, pp. 325-332
Authors:
WOLLHEIM FA
EBERHARDT KB
JOHNSON U
SAXNE T
Citation: Fa. Wollheim et al., HLA DRB1-ASTERISK TYPING AND CARTILAGE OLIGOMERIC MATRIX PROTEIN (COMP) AS PREDICTORS OF JOINT DESTRUCTION IN RECENT-ONSET RHEUMATOID-ARTHRITIS, British journal of rheumatology, 36(8), 1997, pp. 847-849
Authors:
STURFELT G
ROUXLOMBARD P
WOLLHEIM FA
DAYER JM
Citation: G. Sturfelt et al., LOW-LEVELS OF INTERLEUKIN-1 RECEPTOR ANTAGONIST COINCIDE WITH KIDNEY INVOLVEMENT IN SYSTEMIC LUPUS-ERYTHEMATOSUS, British journal of rheumatology, 36(12), 1997, pp. 1283-1289
Citation: Fa. Wollheim, PREDICTORS OF JOINT DAMAGE IN RHEUMATOID-ARTHRITIS, APMIS. Acta pathologica, microbiologica et immunologica Scandinavica, 104(2), 1996, pp. 81-93
Authors:
EBERHARDT K
RYDGREN L
FEX E
SVENSSON B
WOLLHEIM FA
Citation: K. Eberhardt et al., D-PENICILLAMINE IN EARLY RHEUMATOID-ARTHRITIS - EXPERIENCE FROM A 2-YEAR DOUBLE-BLIND PLACEBO-CONTROLLED STUDY, Clinical and experimental rheumatology, 14(6), 1996, pp. 625-631
Authors:
WESTERGRENTHORSSON G
COSTER L
AKESSON A
WOLLHEIM FA
Citation: G. Westergrenthorsson et al., ALTERED DERMATAN SULFATE PROTEOGLYCAN SYNTHESIS IN FIBROBLAST-CULTURES ESTABLISHED FROM SKIN OF PATIENTS WITH SYSTEMIC-SCLEROSIS, Journal of rheumatology, 23(8), 1996, pp. 1398-1406
Citation: Fa. Wollheim, BIOLOGICAL MARKERS OF RHEUMATOID-ARTHRITIS - DO THEY HELP IN EVALUATING AND FOLLOWING PATIENTS, Schweizerische medizinische Wochenschrift, 126, 1996, pp. 18-19
Authors:
STURFELT GK
ROUXLOMBARD P
DAYER JM
WOLLHEIM FA
Citation: Gk. Sturfelt et al., INTERLEUKIN-1 RECEPTOR ANTAGONIST IN THE COURSE OF SLE - LOW-LEVELS COINCIDE WITH KIDNEY INVOLVEMENT, Arthritis and rheumatism, 39(9), 1996, pp. 1611-1611
Citation: K. Eberhardt et al., ASSOCIATIONS OF HLA-DRB AND HLA-DQB GENES WITH 2 AND 5-YEAR OUTCOME IN RHEUMATOID-ARTHRITIS, Annals of the Rheumatic Diseases, 55(1), 1996, pp. 34-39
Authors:
SCHEJA A
AKESSON A
NIEWIEROWICZ I
WALLIN L
WILDT M
WOLLHEIM FA
Citation: A. Scheja et al., COMPUTER-BASED QUANTITATIVE-ANALYSIS OF CAPILLARY ABNORMALITIES IN SYSTEMIC-SCLEROSIS AND ITS RELATION TO PLASMA-CONCENTRATION OF VON-WILLEBRAND-FACTOR, Annals of the Rheumatic Diseases, 55(1), 1996, pp. 52-56
Authors:
WOLLHEIM FA
SAXNE T
EBERHARDT KB
JOHNSSON U
Citation: Fa. Wollheim et al., THE SHARED EPITOPE AND COMP AS PREDICTORS OF EROSIVENESS IN RECENT-ONSET RA, Arthritis and rheumatism, 38(9), 1995, pp. 506-506
Citation: A. Akesson et al., EVALUATION OF CYCLOPHOSPHAMIDE TREATMENT OF SYSTEMIC SCLEROSIS-ASSOCIATED PULMONARY DYSFUNCTION - COMMENT ON THE ARTICLE BY AKESSON ET-AL -REPLY, Arthritis and rheumatism, 38(1), 1995, pp. 147-147
Authors:
SCHEJA A
ESKILSSON J
AKESSON A
WOLLHEIM FA
Citation: A. Scheja et al., INVERSE RELATION BETWEEN PLASMA-CONCENTRATION OF VON-WILLEBRAND-FACTOR AND CREDTA CLEARANCE IN SYSTEMIC-SCLEROSIS, Journal of rheumatology, 21(4), 1994, pp. 639-642